Krsnaa Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 147.16 Cr
- Paid Up Capital ₹ 16.14 Cr
- Company Age 14 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 221.16 Cr
- Satisfied Charges ₹ 319.95 Cr
- Revenue Growth 242.41%
- Profit Growth 1382.55%
- Ebitda 45.93%
- Net Worth 15.12%
- Total Assets 10.95%
About Krsnaa Diagnostics
Krsnaa Diagnostics Limited (KDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 22 December 2010 and has a history of 14 years and two months. Its registered office is in Pune, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543328 and on the National Stock Exchange(NSE) under KRSNAA.
The Corporate was formerly known as Krsna Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 147.16 Cr and a paid-up capital of Rs 16.14 Cr.
The company currently has active open charges totaling ₹221.16 Cr. The company has closed loans amounting to ₹319.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Krsnaa Diagnostics Limited India are Pawan Daga as CFO and Sujoy Bose as Company Secretary. Adesh Kumar, Chetan Desai, Chhaya Palrecha, and Five other members serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
- Apps
Corporate Identity Details
Industry
Who are the key members and board of directors at Krsnaa Diagnostics?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pawan Daga | CFO | 18-Jan-2021 | Current |
Sujoy Bose ![]() | Company Secretary | 07-Sep-2023 | Current |
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yash Mutha ![]() | Whole-Time Director | 31-Jan-2019 | Current |
Prem Pradeep ![]() | Nominee Director | 08-Oct-2020 | Current |
Pallavi Bhatevara ![]() | Whole-Time Director | 01-Apr-2024 | Current |
Chetan Desai ![]() | Director | 25-Apr-2021 | Current |
Adesh Kumar ![]() | Director | 28-May-2022 | Current |
Chhaya Palrecha ![]() | Director | 25-Apr-2021 | Current |
Financial Performance of Krsnaa Diagnostics.
Krsnaa Diagnostics Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 242.41% increase. The company also saw a substantial improvement in profitability, with a 1382.55% increase in profit. The company's net worth Soared by an impressive increase of 15.12%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Krsnaa Diagnostics?
In 2021, Krsnaa Diagnostics had a promoter holding of 66.19% and a public holding of 33.82%. The company had 6 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹221.16 Cr
₹319.95 Cr
Charges Breakdown by Lending Institutions
- Others : 167.40 Cr
- State Bank Of India : 30.00 Cr
- Yes Bank Limited : 23.75 Cr
- Punjab National Bank : 0.01 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
21 Feb 2024 | Yes Bank Limited | ₹23.75 Cr | Open |
26 Aug 2023 | Others | ₹52.00 Cr | Open |
12 Sep 2022 | State Bank Of India | ₹30.00 Cr | Open |
26 Mar 2021 | Others | ₹22.00 Cr | Open |
04 Feb 2020 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Krsnaa Diagnostics?
Krsnaa Diagnostics has a workforce of 3307 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Krsnaa Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krsnaa Diagnostics's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.